varieti
plant
speci
genet
modifi
accumul
vaccin
antigen
human
anim
health
first
vaccin
candid
approach
market
regulatori
burden
anim
vaccin
less
human
use
attract
attent
research
compani
invest
plantmad
vaccin
anim
infecti
diseas
control
increas
dosag
cost
vaccin
anim
infecti
diseas
must
kept
minimum
especi
nonleth
diseas
diminish
anim
welfar
growth
effici
econom
product
storag
deliveri
critic
commerci
becom
clear
transgen
plant
econom
effici
altern
ferment
largescal
product
vaccin
antigen
oral
deliveri
plantmad
vaccin
particularli
attract
sinc
expens
purif
step
avoid
reduc
cost
per
dose
review
cover
current
statu
plantproduc
vaccin
prevent
diseas
anim
focus
barrier
develop
product
method
overcom
vaccin
continu
import
costeffect
way
control
anim
human
infecti
diseas
mean
impact
increas
welfar
decreas
morbid
mortal
sinc
day
jenner
discoveri
year
ago
success
vaccin
strategi
establish
numer
anim
human
diseas
although
vaccin
technolog
made
substanti
progress
basic
concept
remain
major
licens
anim
vaccin
viru
bacteria
either
liveattenu
kill
liveattenu
vaccin
gener
effici
induc
strong
immun
respons
howev
manufactur
use
present
potenti
risk
includ
contamin
risk
manufactur
process
possibl
revert
virul
vivo
inactiv
vaccin
replic
vivo
safer
use
often
lower
level
immunogen
share
risk
manufactur
recombin
subunit
vaccin
circumv
risk
associ
product
whole
cell
vaccin
increas
regulatori
demand
product
anim
infecti
diseas
control
conquer
diseas
subunit
vaccin
identif
suitabl
antigen
abil
elicit
protect
immun
respons
critic
earli
step
known
protect
antigen
express
transgen
plant
could
offer
new
vaccin
strategi
eg
oral
applic
vs
inject
due
low
cost
product
deliveri
new
antigen
discoveri
plant
transient
express
system
competit
avail
product
platform
term
time
scalabl
gleba
et
al
possibl
deliv
plantmad
vaccin
pmv
oral
focu
mani
studi
oral
deliveri
attract
simplic
increas
likelihood
local
mucos
immun
respons
site
infect
howev
amount
antigen
need
oral
deliveri
high
compar
parenter
administr
streatfield
howard
success
oral
vaccin
must
surviv
gastrointestin
condit
must
stimul
mucos
immun
system
provid
protect
subsequ
infect
intestin
epithelium
dual
function
allow
penetr
nutrient
macromolecul
import
growth
develop
provid
barrier
potenti
harm
microorgan
mestecki
et
al
diet
anim
consist
complex
mixtur
protein
macromolecul
potenti
antigen
sinc
food
antigen
usual
elicit
immun
respons
mucos
immun
system
appar
distinguish
harm
pathogen
antigen
harmless
food
antigen
holmgren
et
al
pathogen
antigen
tend
elicit
immunosurveil
lead
activ
immun
defens
wherea
solubl
food
antigen
usual
activ
immunosuppress
state
known
oral
toler
howev
certain
solubl
antigen
includ
cholera
toxin
ct
heatlabil
enterotoxin
escherichia
coli
lt
lectin
bind
enterocyt
effici
fimbria
pig
van
den
broeck
et
al
elicit
immun
respons
upon
oral
administr
strober
et
al
exact
mechan
behind
induct
opposit
mucos
function
complet
understood
unrespons
default
solubl
antigen
holmgren
et
al
mucos
immun
respons
elicit
either
transport
antigen
special
antigen
sampl
cell
design
mcell
receptormedi
transport
epitheli
enterocyt
strober
et
al
neutra
kozlowski
transport
antigen
captur
underli
antigenpres
cell
activ
costimulatori
signal
elicit
immun
respons
immunocompet
site
neutra
kozlowski
addit
dendrit
cell
captur
microorgan
particul
antigen
directli
lumin
content
intestin
rescigno
et
al
rimoldi
rescigno
concept
oral
vaccin
crude
process
plant
materi
express
antigen
demonstr
human
sever
studi
tacket
et
al
tacket
et
al
tacket
et
al
kapusta
et
al
thanavala
et
al
direct
guidelin
human
medicin
hinder
progress
product
behind
first
preliminari
clinic
trial
interest
humanus
plantmad
pharmaceut
pmp
focus
toward
purifi
product
regulatori
load
anim
pharmaceut
less
human
use
veterinari
purpos
oral
vaccin
feed
transgen
plant
remain
attract
efficaci
pmv
prove
target
anim
pig
chicken
lamphear
et
al
zhou
et
al
guerreroandrad
et
al
joensuu
et
al
veterinari
pmp
summar
streatfield
rice
et
al
floss
et
al
review
reflect
current
statu
advantag
challeng
vaccin
antigen
express
plant
give
overview
applic
design
overcom
anim
infecti
diseas
leafi
feedfood
crop
use
vaccin
antigen
product
includ
alfalfa
wigdorovitz
et
al
lettuc
kapusta
et
al
spinach
modelska
et
al
white
clover
legum
alfalfa
white
clover
wide
cultiv
high
protein
capabl
nitrogen
fixat
reduc
product
cost
environment
load
lettuc
spinach
regularli
consum
human
thu
potenti
deliveri
vehicl
human
oral
vaccin
nonfood
model
plant
arabidopsi
also
use
vaccin
antigen
product
small
size
probabl
limit
use
smallscal
proof
principl
studi
gomez
et
al
use
logic
fruit
veget
crop
consum
raw
process
variou
palat
form
without
cook
also
util
vaccin
antigen
product
report
exampl
includ
banana
kumar
et
al
tomato
mcgarvey
et
al
cherri
tomatillo
gao
et
al
potato
haq
et
al
melon
nagesha
et
al
carrot
bouch
et
al
seed
legum
pigeon
pea
satyavathi
et
al
soybean
piller
et
al
peanut
khandelw
et
al
use
produc
vaccin
antigen
maiz
streatfield
et
al
rice
yang
et
al
barley
joensuu
et
al
cereal
crop
use
seedbas
vaccin
antigen
product
nonfood
crop
speci
like
tobacco
attract
option
recombin
protein
product
minim
regulatori
barrier
elimin
risk
entri
food
chain
leav
harvest
flower
significantli
reduc
potenti
gene
leakag
environ
pollen
seed
dispers
unlik
seed
tuber
tobacco
leav
perish
persist
environ
therefor
tobacco
recogn
platform
choic
biopharmaceut
product
common
plant
speci
use
product
vaccin
antigen
tabl
wellestablish
transform
regener
techniqu
avail
tobacco
rel
easi
propag
grow
laboratori
scale
field
condit
tobacco
produc
kgha
fresh
biomass
singl
season
woodlief
et
al
oral
administr
vaccin
antigen
intact
leaf
tissu
certainli
low
cost
approach
presenc
nicotin
alkaloid
could
limit
use
tobacco
lownicotin
tobacco
platform
suitabl
direct
oral
administr
develop
vaccin
antigen
express
fresh
plant
tissu
leav
mason
et
al
fruit
mcgarvey
et
al
tuber
haq
et
al
taproot
bouch
et
al
matur
seed
streatfield
et
al
harvest
fresh
plant
tissu
usual
need
process
freez
preserv
antigen
stabl
form
matur
seed
desicc
allow
longterm
storag
ambient
temperatur
well
fruit
tuber
taproot
store
limit
time
especi
chill
environ
vaccin
antigen
also
express
undifferenti
plant
cell
cultur
cell
suspens
smith
et
al
somat
embryo
callu
cultur
kapusta
et
al
high
overal
protein
content
target
plant
tissu
benefici
highlevel
accumul
recombin
protein
demand
fulfil
leafi
crop
applic
antigen
target
seed
howev
minor
proport
fruit
tuber
tissu
protein
limit
amount
antigen
express
deliv
tissu
antigen
express
level
individu
potato
tuber
tacket
et
al
tomato
fruit
sandhu
et
al
report
vari
increas
longterm
storag
concentr
antigen
tissu
may
need
process
techniqu
freezedri
follow
grind
powder
batch
process
homogen
raw
materi
allow
product
uniform
antigen
dosag
manufactur
similarli
leafi
crop
process
homogen
start
materi
vaccin
antigen
produc
grain
batchtobatch
variat
monitor
directli
harvest
seed
materi
deliv
unprocess
form
anim
howev
care
select
process
techniqu
use
increas
palat
antigen
concentr
streatfield
et
al
context
use
plant
antigen
product
deliveri
system
three
main
option
engin
plant
produc
immunolog
activ
peptid
first
integr
dna
encod
gene
interest
nuclear
organel
genom
plant
gener
stabl
transgen
plant
express
antigen
either
constitut
specif
tissu
stabl
transgen
plant
commonli
obtain
agrobacteriummedi
gene
transfer
bombard
dnacoat
highveloc
goldtungsten
particl
follow
appropri
tissu
cultur
procedur
arabidopsi
speci
labori
tissu
cultur
step
avoid
agrobacterium
floral
dip
vacuum
infiltr
method
review
see
clough
curti
second
option
integr
genet
materi
encod
immunolog
activ
protein
peptid
genom
plant
viru
use
infect
plant
transient
express
system
initi
viru
inocul
plant
protein
peptid
express
either
surfac
viru
particl
fusion
epitop
viral
coat
protein
autonom
protein
produc
byproduct
viru
infect
third
option
transient
gene
express
system
known
agroinfiltr
use
infiltr
engin
agrobacterium
main
characterist
along
major
advantag
disadvantag
express
system
discuss
major
advantag
stabl
transgen
plant
transient
protein
product
system
protein
product
trait
herit
therefor
transmit
multipl
gener
make
scaleup
simpl
allow
establish
seed
stock
ensur
longterm
avail
start
materi
kirk
webb
product
antigen
protein
tissu
transgen
plant
applic
consumpt
present
possibl
tissu
consum
directli
provid
edibl
vaccin
obviat
need
purifi
vaccin
protein
purif
pharmaceut
protein
often
account
final
cost
streatfield
howard
often
limit
step
commerci
product
particularli
import
product
vaccin
livestock
profit
margin
narrow
oral
deliveri
vaccin
antigen
within
plant
follow
limit
process
eg
grind
may
attract
lowcost
way
improv
anim
health
drawback
use
transgen
plant
product
platform
includ
time
requir
regener
analyz
transform
unpredict
express
accumul
scaleup
time
need
seed
product
gener
suffici
transgen
plant
materi
protein
analysi
may
take
sever
month
despit
advanc
field
plant
speci
recalcitr
respect
transform
addit
low
yield
antigen
protein
also
signific
barrier
howev
recent
progress
plastid
transform
enabl
highlevel
svab
maliga
tomato
ruf
et
al
potato
sidorov
et
al
introduc
crop
speci
includ
carrot
kumar
et
al
cotton
kumar
et
al
soybean
dufourmantel
et
al
oilse
rape
hou
et
al
plant
viral
express
system
gener
effici
transgen
plantbas
product
system
term
yield
foreign
protein
express
per
gram
plant
tissu
virusbas
product
system
use
antigen
product
chimer
viru
particl
free
foreign
protein
must
usual
purifi
infect
leaf
tissu
immunogen
peptid
express
form
epitop
fuse
plant
viral
coat
protein
recombin
viral
particl
simpli
purifi
infect
tissu
addit
virion
often
remark
stabl
structur
howev
strict
limit
present
size
insert
introduc
viru
genom
success
assembl
virion
yusibov
et
al
usual
case
peptid
protein
express
autonom
byproduct
viru
infect
transgen
plant
contrast
transgen
plant
materi
particularli
seed
tuber
fruit
store
leaf
tissu
virusinfect
plant
practic
howev
purifi
plant
viru
particl
store
long
period
time
appropri
condit
advantag
plant
viru
platform
express
includ
save
time
labor
variou
genet
construct
test
scale
matter
week
import
featur
vaccin
product
system
emerg
new
pathogen
variant
howev
bulkscal
product
antigen
inconveni
sinc
recombin
plant
virus
need
gener
vitro
inocul
individu
plant
genet
stabil
viru
must
monitor
multipl
passag
possibl
inocul
fieldgrown
plant
viral
vector
transient
express
vaccin
antigen
risk
spread
modifi
plant
virus
would
high
use
system
must
therefor
limit
contain
environ
greenhous
exampl
epitop
vaccin
antigen
success
display
part
chimer
plant
virus
includ
cowpea
mosaic
viru
cpmv
dalsgaard
et
al
tobacco
mosaic
viru
tmv
koo
et
al
alfalfa
mosaic
viru
almv
yusibov
et
al
plum
pox
potyviru
ppv
fernandezfernandez
et
al
potato
viru
x
pvx
marus
et
al
success
coexpress
antigen
employ
tmv
wigdorovitz
et
al
pvx
franconi
et
al
ppv
fernandezfernandez
et
al
agroinfiltr
agrobacterium
cultur
forc
intact
harvest
plant
leaf
tissu
pressur
transgen
express
plant
cell
day
subsequ
harvest
foreign
protein
kapila
et
al
inhibit
gene
silenc
agroinfiltr
leav
shown
increas
recombin
protein
yield
voinnet
et
al
agroinfiltr
conveni
preliminari
laboratoryscal
test
transform
vector
capac
product
small
amount
purifi
recombin
protein
scale
thu
becom
effici
product
platform
largescal
agroinfiltr
current
util
antigen
antibodi
product
canadian
biotechnolog
compani
medicaco
wwwmedicacocom
process
alfalfa
tobacco
plant
daoust
et
al
german
compani
icon
genet
wwwicongenet
com
establish
agroinfiltrationbas
applic
call
magnifect
combin
transfect
effici
agrobacterium
high
express
yield
viral
vector
marillonnet
et
al
recent
magnifect
shown
great
promis
rapid
grammagnitud
scalabl
product
system
antigen
antibodi
santi
et
al
similarli
transient
viral
express
agroinfiltrationbas
product
need
contain
environ
requir
purif
recombin
protein
harvest
limit
scalabl
compar
express
transgen
plant
publish
studi
vaccin
candid
express
plant
anim
infecti
diseas
control
summar
tabl
major
applic
viral
pathogen
like
reason
lack
potenti
microbi
pathogen
lack
costeffect
mean
treat
anim
viru
infect
wherea
microb
infect
usual
control
antibiot
howev
recent
forthcom
ban
nontherapeut
use
antibiot
increas
demand
new
treatment
option
promot
anim
health
european
union
ban
use
antibiot
growth
promot
purpos
januari
anonym
similar
bill
preserv
antibiot
medic
treatment
propos
us
govern
februari
anonym
plantproduc
vaccin
preliminari
test
laboratori
anim
mainli
mice
advantag
exampl
show
protect
target
speci
follow
oral
deliveri
lamphear
et
al
khandelw
et
al
zhou
et
al
guerreroandrad
et
al
instanc
vaccin
anim
also
serv
protect
human
health
rabi
mcgarvey
et
al
yusibov
et
al
ashraf
et
al
ehec
judg
et
al
avian
influenza
mihaliak
webb
exampl
target
diseas
plantproduc
vaccin
develop
would
offer
protect
anim
human
chines
research
group
success
develop
edibl
potatobas
vaccin
chicken
infecti
bronchiti
viru
ibv
zhou
et
al
slice
tuber
express
viral
glycoprotein
administ
three
dose
two
week
week
last
administr
chicken
challeng
ibv
oral
immun
chicken
develop
virusspecif
antibodi
respons
protect
ibv
wu
et
al
succeed
vaccin
chicken
infecti
bursal
diseas
viru
ibdv
chicken
oral
immun
arabidopsi
crude
extract
protect
manner
similar
anim
receiv
commerci
inject
vaccin
efficaci
vaccin
verifi
three
replic
experi
chicken
per
group
ident
result
wu
et
al
includ
first
fdaapprov
plantproduc
vaccin
made
tobacco
cell
cultur
vermij
waltz
newcastl
diseas
viru
target
mani
recent
studi
plantmad
vaccin
viru
surfac
glycoprotein
f
hn
epitop
display
surfac
cucumb
mosaic
viru
particl
zhao
hammond
natilla
et
al
chimer
viru
particl
assembl
tobacco
leav
immunogen
determin
full
length
glycoprotein
express
transgen
potato
berinstein
et
al
tobacco
hahn
et
al
leav
maiz
guerreroandrad
et
al
rice
seed
yang
et
al
antigen
shown
immunogen
protect
chicken
oral
deliveri
transgen
peanut
plant
express
bovin
rinderpest
viru
hemaglutinin
report
rais
immun
respons
cattl
khandelw
et
al
cow
fed
three
time
g
transgen
leaf
tissu
oral
vaccin
abl
rais
virusspecif
antibodi
also
neutral
viru
vitro
immunogen
tmvbase
vaccin
bovin
herp
viru
bhv
studi
cattl
perez
filgueira
et
al
immunogen
glycoprotein
produc
byproduct
tmvinocul
tobacco
plant
crude
plant
extract
emulsifi
oil
subsequ
inject
cow
abl
rais
specif
humor
cellular
immun
respons
importantli
anim
protect
bhv
similar
level
cow
vaccin
commerci
vaccin
foot
mouth
diseas
viru
fmdv
infect
mani
meatand
milkproduc
domest
anim
includ
cow
argentinean
laboratori
vaccin
fmdv
extens
develop
vaccin
base
viral
structur
protein
express
report
arabidopsi
potato
tuber
carrillo
et
al
alfalfa
leav
wigdorovitz
et
al
du
santo
et
al
du
santo
wigdorovitz
alfalfa
chosen
platform
phytochem
rev
oral
deliveri
protect
immun
respons
report
mice
wigdorovitz
et
al
author
also
develop
plantproduc
vaccin
bovin
rotaviru
infect
epitop
rotaviru
protein
express
tmvbase
transient
system
perez
filgueira
et
al
transgen
alfalfa
plant
immunogen
determin
mous
model
importantli
alfalfaf
mice
develop
virusspecif
antibodi
respons
pup
subsequ
protect
viral
challeng
passiv
lactogen
immun
furthermor
express
bovin
rotaviru
protein
report
transplastom
tobacco
plant
birchmachin
et
al
potato
tuber
matsumura
et
al
canadian
group
investig
plantproduc
vaccin
bovin
pneumon
pasteurellosi
ship
fever
caus
mannheimia
haemolytica
transgen
white
clover
alfalfa
ziauddin
et
al
plant
express
fragment
leucotoxin
fuse
green
fluoresc
protein
gfp
gener
immunogen
fusion
protein
establish
rabbit
intramuscular
inject
gener
antibodi
also
neutral
relat
leucotoxin
vitro
recent
dow
agrosci
launch
licens
agreement
produc
leucotoxin
antigen
plantcellbas
platform
anonym
colon
factor
bovin
diarrheacaus
enterohemorragh
e
coli
ehec
express
tobacco
plant
judg
et
al
histag
intimin
purifi
plant
extract
inject
intraperiton
mice
altern
mice
fed
transgen
plant
materi
follow
ehec
challeng
reduc
e
coli
shed
observ
parenter
immun
group
well
mice
receiv
oral
boost
intraperiton
prime
develop
plantproduc
vaccin
porcin
transmiss
gastroenter
viru
tgev
carri
sever
research
group
neutral
viru
spike
protein
antigen
express
leaf
tissu
transgen
tobacco
tuboli
et
al
arabidopsi
plant
gomez
et
al
potato
tuber
gomez
et
al
maiz
seed
streatfield
et
al
plantproduc
spike
protein
antigen
immunogen
mice
follow
parenter
oral
administr
gomez
et
al
gomez
et
al
tuboli
et
al
immun
wean
piglet
intraperiton
crude
tobacco
extract
detect
virusspecif
neutral
antibodi
three
inject
use
maiz
seed
edibl
deliveri
vehicl
tgev
studi
streatfi
colleagu
efficaci
plantmad
vaccin
present
multipl
experi
piglet
streatfield
et
al
lamphear
et
al
addit
found
antigen
stabl
storag
variou
condit
author
abl
concentr
antigen
mill
techniqu
lamphear
et
al
develop
plantproduc
vaccin
porcin
epidem
diarrhea
viru
pedv
establish
korean
research
group
pedvneutr
epitop
express
tobacco
bae
et
al
kang
et
al
potato
kim
et
al
rice
seed
oszvald
et
al
tobaccoderiv
protein
also
report
rais
virusspecif
antibodi
mice
oral
deliveri
bae
et
al
enterotoxigen
e
coli
etec
express
fimbria
caus
diarrhea
variou
farm
anim
includ
pig
chicken
cow
wherea
etec
pathogen
pig
van
den
broeck
et
al
et
al
major
subunit
protein
fimbria
express
leav
tobacco
huang
et
al
joensuu
et
al
liang
et
al
alfalfa
joensuu
et
al
seed
barley
joensuu
et
al
fimbrial
subunit
express
leav
soybean
plant
piller
et
al
garg
et
al
subunit
vaccin
shown
immunogen
partial
protect
oral
deliveri
wean
piglet
joensuu
et
al
immunogen
etec
vaccin
confirm
vaccin
mice
parenter
crude
leaf
extract
piller
et
al
addit
candid
vaccin
base
colon
factor
express
etec
heatlabil
toxin
subunit
b
plant
wide
studi
ltb
form
homopentam
mediat
bind
toxin
enterocyt
autoassembl
pentam
observ
ltb
encod
gene
express
transgen
plant
success
exampl
includ
tobacco
kang
et
al
lettuc
leav
kim
et
al
potato
tuber
haq
et
al
mason
et
al
lauterslag
et
al
maiz
streatfield
et
al
chikwamba
et
al
soybean
seed
moravec
et
al
oral
administ
plantmad
ltb
abl
protect
mice
subsequ
challeng
ltholotoxin
immunogen
antigen
also
shown
human
tacket
et
al
tacket
et
al
oral
immun
herd
farm
anim
subunit
vaccin
requir
bulkscal
product
antigen
low
express
level
still
remain
one
major
hurdl
vaccin
product
transgen
plant
tabl
high
express
level
equal
import
adequates
oral
dose
costeffect
purif
vaccin
antigen
overal
biomass
yield
crop
speci
intrins
protein
content
plant
tissu
defin
capac
chosen
product
system
howev
multipl
factor
determin
final
antigen
content
product
platform
achiev
high
yield
express
construct
design
must
consid
stage
gene
express
transcript
protein
stabil
promot
select
control
transcript
transgen
perhap
import
compon
express
construct
sever
promot
identifi
provid
high
level
gene
express
plant
commonli
use
promot
control
antigen
express
dicotyledon
plant
speci
strong
constitut
cauliflow
mosaic
viru
promot
camv
version
camv
duplic
transcript
enhanc
region
also
use
increas
gene
express
smith
et
al
warzecha
et
al
dong
et
al
anoth
strong
candid
promot
synthet
super
promot
ni
et
al
success
use
drive
vaccin
antigen
express
plant
tuboli
et
al
pogrebnyak
et
al
express
vaccin
antigen
potato
auxininduc
mannopin
synthas
ma
dual
promot
system
wide
use
langridg
colleagu
arakawa
et
al
arakawa
et
al
arakawa
et
al
yu
langridg
group
prefer
tuberspecif
patatin
promot
mason
et
al
lauterslag
et
al
maiz
camv
promot
use
accumul
vaccin
antigen
seed
chikwamba
et
al
howev
effici
antigen
product
achiev
maiz
seedspecif
czein
promot
chikwamba
et
al
streatfield
howard
gener
wide
use
promot
control
transgen
express
monocotyledon
plant
constitut
maiz
promot
christensen
quail
seedspecif
gene
express
dicotyledon
plant
phaseolin
arcelin
promot
deriv
common
bean
phaseolu
vulgari
shown
high
accumul
recombin
antibodi
de
jaeger
et
al
van
droogenbroeck
et
al
transcript
matur
transcript
protect
prematur
degrad
transport
effici
cytoplasm
translat
machineri
result
posttranscript
process
event
like
cap
splice
polyadenyl
major
effect
level
protein
produc
plant
cell
gutierrez
et
al
introduct
intron
express
construct
shown
increas
stabil
mrna
topfer
et
al
particularli
monocot
plant
introduct
intron
elev
express
level
marker
gene
calli
et
al
maa
et
al
polyadenyl
signal
also
strongli
influenc
stabil
mrna
level
gene
express
plant
cell
ingelbrecht
et
al
hunt
wide
use
polyadenyl
signal
vaccin
applic
includ
camv
transcript
huang
et
al
piller
et
al
soybean
veget
storag
protein
vsp
richter
et
al
vieira
da
silva
et
al
agrobacterium
nopalin
synthas
no
octopin
synthas
oc
gene
mason
et
al
aziz
et
al
richter
et
al
direct
comparison
three
differ
polyadenyl
signal
potato
found
plant
vsp
potato
proteinas
inhibitor
polyadenyl
signal
accumul
hepat
viru
b
surfac
antigen
hbsag
quantiti
sever
time
higher
plant
transform
express
phytochem
rev
vector
nostermin
indic
posttranscript
effect
contribut
strongli
enhanc
accumul
hepat
b
surfac
antigen
gener
synthet
antigenencod
gene
enabl
elimin
potenti
intern
methyl
polyadenyl
site
mrna
secondari
structur
hairpin
prematur
transcript
termin
site
ensur
effici
transcript
stabil
gener
transcript
dong
et
al
initi
mrna
translat
often
ratelimit
step
polypeptid
synthesi
plant
kawaguchi
baileyserr
translat
initi
optim
match
translat
start
site
kozak
consensu
plant
joshi
et
al
initi
rate
translat
may
becom
limit
lack
suitabl
trna
inde
gene
foreign
origin
may
suboptim
codon
composit
plant
translat
machineri
increas
level
protein
express
report
plant
modif
genecod
sequenc
bacteri
origin
perlak
et
al
adang
et
al
horvath
et
al
similarli
optim
gene
sequenc
plant
codon
usag
enhanc
express
variou
vaccin
antigen
e
coli
heat
labil
enterotoxin
subunit
b
ltb
cholera
toxin
subunit
b
ctb
kang
et
al
exampl
ltb
accumul
enhanc
potato
tuber
codonoptim
gene
use
instead
unmodifi
ltb
gene
howev
report
effect
codon
optim
gene
viral
origin
limit
perhap
viral
gene
express
alreadi
optim
express
eukaryot
codon
optim
limit
impact
rna
leader
sequenc
plant
viral
origin
identifi
boost
antigen
express
plant
dowson
day
et
al
wide
use
untransl
region
use
antigen
applic
includ
leader
sequenc
tobacco
etch
viru
tev
thanavala
et
al
mason
et
al
richter
et
al
dong
et
al
tmv
x
element
richter
et
al
matsumura
et
al
biemelt
et
al
subcellular
target
optim
yield
glycosyl
subcellular
environ
recombin
protein
accumul
influenc
fold
assembl
posttransl
modif
factor
surround
ph
presenc
chaperon
proteas
affect
antigen
stabil
therefor
accumul
recombin
protein
direct
secretori
pathway
ntermin
signal
peptid
plant
nativ
signal
appear
work
equal
well
secret
protein
cotransl
synthes
endoplasm
reticulum
er
transport
default
golgi
network
apoplast
presenc
suitabl
signal
direct
vacuol
matsuoka
nakamura
apoplast
depend
protein
size
structur
retain
cell
wall
matrix
secret
cell
er
oxid
environ
abund
molecular
chaperon
proteas
compar
analysi
recombin
antibodi
shown
accumul
effici
target
secretori
pathway
cell
cytoplasm
schillberg
et
al
also
shown
vaccin
antigen
richter
et
al
target
synthesi
hbsag
apoplast
vacuol
found
accumul
level
enhanc
compar
cytoplasmtarget
potato
plant
streatfield
et
al
studi
subcellular
target
ltb
maiz
seed
report
target
apoplast
vacuol
increas
express
level
respect
compar
cytoplasm
secret
protein
retain
er
though
use
ctermin
se
hkdel
peptid
munro
pelham
enhanc
accumul
recombin
antibodi
target
secretori
pathway
conrad
fiedler
similarli
increas
ltb
accumul
shown
tobacco
potato
plant
protein
retain
er
haq
et
al
contrast
accumul
ltb
retain
er
maiz
seed
onetenth
protein
secret
streatfield
et
al
recombin
protein
also
target
organel
like
mitochondria
plastid
done
ad
ntermin
transit
peptid
recogn
organel
transport
machineri
deliv
protein
organel
glaser
soll
richter
et
al
unabl
detect
viral
protein
hbsag
target
chloroplast
maiz
seed
target
bacteri
ltb
plastid
led
increas
compar
cytosol
target
reach
level
obtain
apoplast
er
vacuolar
target
streatfield
et
al
contrari
faeg
major
subunit
etec
fimbria
accumul
higher
level
chloroplast
cytosol
er
apoplast
huang
et
al
van
moll
et
al
candid
vaccin
antigen
includ
protein
peptid
viral
bacteri
origin
well
tumor
autoantigen
protein
bacteri
origin
glycosyl
antigen
includ
viral
surfac
protein
often
heavili
glycosyl
host
cell
appropri
glycosyl
vaccin
antigen
achiev
appropri
subcellular
target
glycosyl
desir
antigen
direct
er
level
glycosyl
affect
retain
antigen
peptid
er
instead
secret
golgi
apparatu
carbohydr
group
ad
fay
et
al
correct
glycosyl
prerequisit
yelverton
et
al
alter
judg
et
al
immunogen
vaccin
antigen
glycosyl
avoid
target
accumul
antigen
cytoplasm
intracellular
plant
organel
altern
addit
carbohydr
prevent
mutat
put
glycosyl
site
antigen
peptid
mammal
plant
similar
structur
core
highmannos
glycan
differ
glycosyl
exist
plant
glycan
use
fucos
linkag
rather
fucos
linkag
found
mammal
addit
xylos
linkag
lack
sialic
acid
moieti
typic
mammalian
glycosyl
fay
et
al
complet
mammal
plant
glycosyl
report
date
consider
interest
review
see
saintjoredupa
et
al
fuse
peptid
whole
protein
poor
stabil
known
stabl
protein
improv
stabil
select
antigen
plant
tissu
subsequ
vaccin
deliveri
approach
commonli
use
peptid
produc
plant
viru
express
system
also
use
optim
antigen
express
stabli
transform
plant
vaccin
antigen
fusion
partner
includ
green
fluoresc
protein
gfp
molina
et
al
ziauddin
et
al
ctb
arakawa
et
al
yu
langridg
kim
et
al
molina
et
al
molina
et
al
cta
yu
langridg
bglucuronidas
gu
gil
et
al
du
santo
et
al
antigen
fusion
marker
gene
also
allow
antigen
product
screen
conveni
canadian
compani
sembiosi
genet
inc
wwwsembiosysca
establish
product
system
recombin
protein
express
oilse
crop
fusion
oleosin
parment
et
al
fusion
protein
accumul
oil
bodi
extract
use
simpl
extract
procedur
recombin
protein
releas
fusion
partner
proteolyt
cleavag
anoth
applic
base
protein
fusion
introduc
spanish
compani
era
biotech
wwwerabiotechcom
introduc
product
system
recombin
protein
fuse
peptid
deriv
storag
protein
accumul
hostindepend
erderiv
protein
bodi
separ
high
densiti
similarli
fusion
elastinlik
polypeptid
elp
simplifi
purif
procedur
recombin
protein
elp
undergo
revers
thermal
denatur
use
temperatur
base
nonchromatograph
separ
meyer
chilkoti
elpfus
also
report
enhanc
express
level
recombin
protein
plant
scheller
et
al
patel
et
al
chloroplast
transform
provid
better
gene
express
capac
nuclear
genet
engin
mainli
high
transgen
copi
number
singl
cell
possess
copi
plastid
genom
transgen
introduc
chloroplast
genom
sitespecif
integr
despit
high
accumul
level
transcript
transgen
silenc
report
transplastom
plant
lee
et
al
dhingra
et
al
similarli
lack
posttranscript
gene
silenc
evid
accumul
bacteri
cri
toxin
phytochem
rev
total
solubl
protein
tsp
transplastom
tobacco
line
de
cosa
et
al
addit
chloroplast
offer
contain
environ
within
plant
cell
potenti
planttox
compound
success
express
lee
et
al
leelavathi
et
al
drawback
chloroplast
complet
protein
posttranscript
modif
best
suit
express
protein
requir
complic
assembl
glycosyl
success
exampl
vaccin
antigen
express
tobacco
chloroplast
includ
ctb
daniel
et
al
tetc
fragment
tetanu
toxoid
tregon
et
al
anthrax
protect
antigen
aziz
et
al
risk
regulatori
issu
associ
use
plant
product
vaccin
antigen
examin
vaccin
antigen
product
plant
list
gene
transfer
allergen
oral
toler
inconsist
dosag
worker
exposur
detriment
effect
environ
six
main
risk
suggest
sever
way
mitig
risk
includ
stewardship
activ
risk
manag
product
qualiti
standard
pharma
planta
european
consortium
biopharmaceut
produc
plant
look
situat
show
complex
regul
genet
modifi
crop
intertwin
regul
pharmaceut
product
creat
challeng
environ
approv
sparrow
et
al
clear
paper
regulatori
issu
transgen
plant
level
product
safeti
efficaci
level
import
technic
challeng
associ
engin
plant
produc
vaccin
antigen
long
effort
produc
vaccin
antigen
whole
plant
although
work
matur
point
field
test
clinic
evalu
first
plant
base
veterinari
vaccin
approv
regulatori
author
world
produc
seal
steril
plant
cell
cultur
vermij
waltz
oral
vaccin
newcastl
diseas
chicken
approv
unit
state
depart
agricultur
regist
januari
dow
agrosci
fact
vaccin
one
either
field
greenhous
product
went
forward
first
might
speak
import
pharmaceut
regul
requir
product
uniform
safeti
efficaci
core
avoid
regulatori
barrier
though
judiosci
choic
product
platform
might
best
way
advanc
vaccin
antigen
produc
plant
although
manner
crop
platform
consid
product
vaccin
antigen
reason
choic
particular
platform
alway
clear
appear
easi
access
enabl
technolog
like
express
vector
transform
protocol
product
capabl
biosafeti
driven
interest
oral
vaccin
gra
gener
recogn
safe
statu
mani
crop
prevail
belief
food
crop
like
maiz
rice
ideal
platform
begin
late
laboratori
recogn
food
crop
would
regulatori
barrier
focus
effort
develop
nonfood
platform
brandl
et
al
earli
canadian
regulatori
agenc
also
began
understand
risk
associ
use
food
crop
actual
issu
one
year
moratorium
field
test
allow
regul
catch
technolog
develop
canadian
food
inspect
agenc
outcom
recommend
food
feed
crop
use
platform
recombin
pharmaceut
product
although
much
reaction
industri
point
follow
strong
catalyst
chang
becam
known
prodigen
affair
texa
base
plant
recombin
protein
compani
fail
respons
postharvest
monitor
contamin
soybean
crop
maiz
produc
vaccin
hileman
compani
fine
eventu
ceas
oper
year
follow
event
number
molecular
farm
field
test
maiz
conduct
us
drop
two
like
result
clear
understand
liabil
associ
use
food
crop
fox
sinc
event
call
exclus
use
nonfood
crop
quit
loud
mani
investig
switch
nonfood
contain
system
anonym
fox
murphi
constrain
intellectu
properti
portfolio
technolog
capabl
research
program
could
chang
suffer
consequ
unwilling
regulatori
system
accommod
system
along
great
deal
public
resist
fox
fox
waltz
given
product
safeti
efficaci
challeng
alreadi
associ
bring
recombin
vaccin
antigen
market
best
platform
must
one
add
regulatori
burden
fact
speak
fact
edibl
plant
made
vaccin
longer
thought
food
instead
pmv
regul
usda
fda
prescrib
physician
veterinarian
use
nonfood
crop
product
platform
would
go
long
way
complet
shift
think
first
pmv
reach
market
like
veterinari
use
sinc
regulatori
process
less
stringent
human
vaccin
prove
full
potenti
product
platform
transgen
plant
express
vaccin
antigen
must
follow
foot
step
plant
cell
cultur
base
vaccin
approv
fda
oral
deliveri
econom
conveni
way
administ
veterinari
vaccin
limit
amount
studi
address
efficaci
pmv
final
host
effort
point
optim
antigen
dosag
administr
schedul
prove
full
valu
oral
deliveri
pmv
ban
prophylact
use
livestock
antibiot
drive
demand
toward
new
product
promot
anim
health
due
recent
advanc
transient
plant
express
system
compet
current
vaccin
product
platform
term
yield
speed
econom
feasibl
mani
veterinari
applic
still
reli
openfield
cultiv
oral
administr
transgen
plant
mani
vaccin
antigen
highli
host
specif
pharmacolog
inact
nontox
secondari
host
safeti
applic
need
evalu
separ
health
environment
effect
veterinari
vaccineproduc
plant
might
significantli
differ
exist
approv
gm
crop
cultivar
addit
sever
strategi
develop
improv
contain
safeti
plant
biopharm
one
major
issu
confront
public
percept
biopharm
food
crop
potenti
contamin
human
food
chain
product
veterinari
vaccin
nonfood
dedic
feed
crop
might
need
step
toward
accept
approv
openfield
product
pmv
anonym
